Endocrinopathies Associated with Checkpoint Inhibitor Immunotherapy-Recording | Endocrinopathies Associated with Checkpoint Inhibitor Immunotherapy

Recording | Endocrinopathies Associated with Checkpoint Inhibitor Immunotherapy

Video Transcription

Video Summary

The video transcript discusses immunotherapy induced endocrinopathies. The speaker, Dr. Shaishav Dhage, provides an overview of immunotherapy, focusing on immune checkpoint inhibitors, and their impact on the immune system's response to cancer. He explains that immunotherapy can cause toxicities in various organs, including the endocrine system. The most common endocrine toxicities include thyroid and pituitary disorders, adrenalitis, type 1 diabetes mellitus, and thyroid eye disease. Dr. Dhage emphasizes the importance of educating patients about the potential side effects of immunotherapy and their management. He discusses the principles of treatment for these toxicities, which include holding or discontinuing treatment, high-dose steroid therapy, and hormone replacement therapy. He also highlights the need for close monitoring and long-term follow-up for these patients. The presentation also includes case studies to illustrate the diagnosis and management of immunotherapy induced endocrinopathies. Overall, the video transcript provides an informative overview of the topic, helping healthcare professionals better understand and manage these potential side effects of immunotherapy.

Keywords

immunotherapy induced endocrinopathies

immune checkpoint inhibitors

immune system response to cancer

endocrine toxicities

thyroid disorders

pituitary disorders

adrenalitis

type 1 diabetes mellitus

thyroid eye disease


EndoCareers \| Contact Us \| Privacy Policy \| Terms of Use	CONNECT WITH US
© 2021 Copyright Endocrine Society. All rights reserved.	2055 L Street NW, Suite 600 \| Washington, DC 20036 202.971.3636 \| 888.363.6274